The acquisition and application of absorption, distribution, metabolism and excretion (ADME) data in agricultural chemical safety assessments

被引:100
作者
Barton, HA
Pastoor, TP
Baetcke, K
Chambers, JE
Diliberto, J
Doerrer, NG
Driver, JH
Hastings, CE
Iyengar, S
Krieger, R
Stahl, B
Timchalk, C
机构
[1] ILSI, Hlth & Environm Sci Inst, Washington, DC 20005 USA
[2] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA
[3] Syngenta Crop Protect, Greensboro, NC USA
[4] US EPA, Off Pesticide Programs, Washington, DC 20460 USA
[5] Mississippi State Univ, Mississippi State, MS 39762 USA
[6] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA
[7] Infoscicom, Manassas, VA USA
[8] BASF Corp, Res Triangle Pk, NC USA
[9] Bayer CropSci, Monheim, Germany
[10] Univ Calif Riverside, Riverside, CA 92521 USA
[11] Bayer CropSci, Sophia Antipolis, France
[12] Pacific NW Natl Lab, Richland, WA 99352 USA
关键词
absorption; ADME; agricultural chemicals; distribution; excretion; metabolism; pharmacokinetics; tiered testing;
D O I
10.1080/10408440500534362
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A proposal has been developed by the Agricultural Chemical Safety Assessment (ACSA) Technical Committee of the ILSI Health and Environmental Sciences Institute (HESI) for an improved approach to assessing the safety of crop protection chemicals. The goal is to ensure that studies are scientifically appropriate and necessary without being redundant, and that tests emphasize toxicological endpoints and exposure durations that are relevant for risk assessment. Incorporation of pharmacokinetic studies describing absorption, distribution, metabolism, and excretion is an essential tool for improving the design and interpretation of toxicity studies and their application for safety assessment. A tiered approach is described in which basic pharmacokinetic studies, similar to those for pharmaceuticals, are conducted for regulatory submission. Subsequent tiers provide additional information in an iterative manner, depending on pharmacokinetic properties, toxicity study results, and the intended uses of the compound.
引用
收藏
页码:9 / 35
页数:27
相关论文
共 109 条
[1]  
*AM C GOV IND HYG, 2002, TLVS BEIS THRESH LIM
[2]   Computational pharmacokinetics during developmental windows of susceptibility [J].
Barton, HA .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2005, 68 (11-12) :889-900
[3]   Family approach for estimating reference concentrations/doses for series of related organic chemicals [J].
Barton, HA ;
Deisinger, PJ ;
English, JC ;
Gearhart, JM ;
Faber, WD ;
Tyler, TR ;
Banton, MI ;
Teeguarden, J ;
Andersen, ME .
TOXICOLOGICAL SCIENCES, 2000, 54 (01) :251-261
[4]   An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons [J].
Brandon, EFA ;
Raap, CD ;
Meijerman, I ;
Beijnen, JH ;
Schellens, JHM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (03) :233-246
[5]  
BRODBERG RK, 1990, HS1559 CAL DEP PEST
[6]   DOSE-DEPENDENT METABOLISM AND DOSE SETTING IN CHRONIC STUDIES [J].
BUS, JS ;
REITZ, RH .
TOXICOLOGY LETTERS, 1992, 64-5 :669-676
[7]   Agricultural chemical safety assessment: A multisector approach to the modernization of human safety requirements [J].
Carmichael, NG ;
Barton, HA ;
Boobis, AR ;
Cooper, RL ;
Dellarco, VL ;
Doerrer, NG ;
Fenner-Crisp, PA ;
Doe, JE ;
Lamb, JC ;
Pastoor, TP .
CRITICAL REVIEWS IN TOXICOLOGY, 2006, 36 (01) :1-7
[8]   ORAL AND DERMAL PHARMACOKINETICS OF TRICLOPYR IN HUMAN VOLUNTEERS [J].
CARMICHAEL, NG ;
NOLAN, RJ ;
PERKINS, JM ;
DAVIES, R ;
WARRINGTON, SJ .
HUMAN TOXICOLOGY, 1989, 8 (06) :431-437
[9]   PHARMACOKINETICS AND TOXICITY TESTING [J].
CLARK, B ;
SMITH, DA .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1984, 12 (04) :343-385
[10]   Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry [J].
Clewell, HJ ;
Teeguarden, J ;
McDonald, T ;
Sarangapani, R ;
Lawrence, G ;
Covington, T ;
Gentry, R ;
Shipp, A .
CRITICAL REVIEWS IN TOXICOLOGY, 2002, 32 (05) :329-389